EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSPTIG00000003012
Gene Symbol: ERBB2
2 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSPTIG00000000947
Gene Symbol: ERBB3
2 Cross references
282 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSPTIG00000007031
Gene Symbol: ERBB4
1 Cross references
236 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSPTIG00000004545
Gene Symbol: ESR2
2 Cross references
273 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSPTIG00000020932
Gene Symbol: ESRRG
2 Cross references
277 Possible Orthologues:

Exportin 1

Ensembl ID : ENSPTIG00000012259
Gene Symbol: XPO1
2 Cross references
304 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSPTIG00000014449
Gene Symbol: FDFT1
2 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSPTIG00000006863
Gene Symbol: FNTA
2 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSPTIG00000001134
Gene Symbol: FNTB
2 Cross references
210 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSPTIG00000006853
Gene Symbol: FAAH
2 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSPTIG00000020049
Gene Symbol: FAP
2 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSPTIG00000007794
Gene Symbol: FGF2
1 Cross references
117 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).